BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 305781)

  • 1. Effect of altered lymphocyte function on immunologic disorders in NZB/NZW mice. III. Acceleration of disease by thymosin.
    Mehta J; Knotts L; Craig C; Burkholder S; Miller C; Hahn B
    Arthritis Rheum; 1978 Mar; 21(2):196-203. PubMed ID: 305781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of thymic factors. II. Failure of thymosin to alter the natural history of NZB and NZB/NZW mice.
    Gershwin ME; Steinberg AD; Ahmed A; Derkay C
    Arthritis Rheum; 1976; 19(5):862-6. PubMed ID: 1085626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Class-specific regulation of anti-DNA antibody synthesis and the age-associated changes in (NZB x NZW)F1 hybrid mice.
    Sekigawa I; Okada T; Noguchi K; Ueda G; Hirose S; Sato H; Shirai T
    J Immunol; 1987 May; 138(9):2890-5. PubMed ID: 2952727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced response of autoantibody-secreting B cells from young NZB/NZW mice to T-cell-derived differentiation signals.
    Herron LR; Coffman RL; Kotzin BL
    Clin Immunol Immunopathol; 1988 Feb; 46(2):314-27. PubMed ID: 3257428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of suppressor T cells in adult NZB/NZW mice.
    Krakauer RS; Waldmann TA; Strober W
    J Exp Med; 1976 Sep; 144(3):662-73. PubMed ID: 1085336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro effect of thymosin on T-lymphocyte rosette formation in rheumatic diseases.
    Moutsopoulos H; Fye KH; Sawada S; Becker MJ; Goldstein A; Talal N
    Clin Exp Immunol; 1976 Dec; 26(3):563-73. PubMed ID: 795579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Splenic immunoglobulin-secreting cells and their regulation in autoimmune mice.
    Theofilopoulos AN; Shawler DL; Eisenberg RA; Dixon FJ
    J Exp Med; 1980 Feb; 151(2):446-66. PubMed ID: 6444324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Responses to T-cell and B-cell mitogens in autoimmune Palmerston North and NZB/NZW mice.
    Walker SE; Hewett JE
    Clin Immunol Immunopathol; 1984 Mar; 30(3):469-78. PubMed ID: 6607803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defects in the regulation of anti-DNA antibody production in aged lupus-prone (NZB x NZW)F1 mice: analysis of T-cell lymphokine synthesis.
    Sato MN; Minoprio P; Avrameas S; Ternynck T
    Immunology; 1995 May; 85(1):26-32. PubMed ID: 7635519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The in vitro and in vivo induction of anti-double-stranded DNA antibodies in normal and autoimmune mice.
    Fish F; Ziff M
    J Immunol; 1982 Jan; 128(1):409-14. PubMed ID: 6976378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular basis of in vitro anti-DNA antibody production: evidence for T cell dependence of IgG-class anti-DNA antibody synthesis in the (NZB X NZW)F1 hybrid.
    Sekigawa I; Ishida Y; Hirose S; Sato H; Shirai T
    J Immunol; 1986 Feb; 136(4):1247-52. PubMed ID: 3484766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyclonal B cell activation arises from different mechanisms in lupus-prone (NZB x NZW)F1 and MRL/MpJ-lpr/lpr mice.
    Merino R; Iwamoto M; Fossati L; Izui S
    J Immunol; 1993 Dec; 151(11):6509-16. PubMed ID: 7902378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural history of murine lupus. Modulation by sex hormones.
    Talal N
    Arthritis Rheum; 1978 Jun; 21(5 Suppl):S58-63. PubMed ID: 352366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymosin corrects the abnormal DNA synthetic response of NZB mouse thymocytes.
    Dauphinee MJ; Talal N; Goldstein AL; White A
    Proc Natl Acad Sci U S A; 1974 Jul; 71(7):2637-41. PubMed ID: 4546960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressor cell activity in a male infant with T-and B-lymphocyte dysfunction treated with thymosin.
    Hanson LA; Lindholm L; Carlsson B; Fasth A; Fälström SP; Wadsworth C; Värendh G
    Scand J Immunol; 1976; 5(10):1227-31. PubMed ID: 1087748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymosin administration in autoimmune disorders.
    Lavastida MT; Goldstein AL; Daniels JC
    Thymus; 1981 Feb; 2(4-5):287-95. PubMed ID: 6972106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with high doses of anti-IgM prevents, but with lower doses accelerates autoimmune disease in (NZW x BXSB)F1 hybrid mice.
    Cerny A; Starobinski M; Hügin AW; Sutter S; Zinkernagel RM; Izui S
    J Immunol; 1987 Jun; 138(12):4222-8. PubMed ID: 3495583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of thymosin on human lymphocyte subpopulations in vitro].
    Shergin SM; Shubinskiĭ GZ; Kozhevnikov VS; Musatov MI; Kudaeva OT
    Biull Eksp Biol Med; 1980 Feb; 89(2):192-4. PubMed ID: 6966166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel function of B lymphocytes from normal mice to suppress autoimmunity in (NZB x NZW)F1 mice.
    Ono S; Shao D; Yamada S; Yang Y; Yamashita M; Hamaoka T
    Immunology; 2000 May; 100(1):99-109. PubMed ID: 10809965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of L-canavanine on immune function in normal and autoimmune mice: disordered B-cell function by a dietary amino acid in the immunoregulation of autoimmune disease.
    Prete PE
    Can J Physiol Pharmacol; 1985 Jul; 63(7):843-54. PubMed ID: 3876146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.